Prostate cancer (PCa) is the second leading cause of cancer-related deaths in the United
States. The African (AA) descent has greater incidence and mortality rates of PCa as …

Introduction: Prostate cancer (PCa) is one of the deadliest and most common causes of
malignancy and death in men worldwide, with a higher prevalence and mortality in …

Prostate cancer (PCa) symptoms are commonly confused with benign prostate hyperplasia
(BPH), particularly in the early stages due to similarities between symptoms, and in some …

Health endpoint and risk of carcinogenic among people enhancement due to Exposures to
toxic air pollutants. The purpose of this study was investigation of a carcinogenic risk …

It is being debated whether prostate-specific antigen (PSA)-based screening effectively
reduces prostate cancer mortality. Some of the uncertainty could be related to deficiencies in …

Background: There is variable reporting on the benefits of a 200 μg/d selenium
supplementation towards reducing prostate cancer impacts. The current analysis is to …

Administration of testosterone (T) is associated with increased serum T concentrations and
improved physical performance in women. However, the inter-individual variation in T …

Prostate cancer (PCa) is one of the most significant male health concerns worldwide. Single
nucleotide polymorphisms (SNPs) are becoming increasingly strong candidate biomarkers …

Prostate cancer (PC) is one of the principal causes of cancer death worldwide. The mortality
rate for PC in the Caribbean is higher than in many developed countries, and there is a …

Introduction Aldo-keto reductase 1C3 (AKR1C3) is known for multiple functions including its
catalytic activity towards producing extra-testicular androgen. The present study is towards …